Karen J. Santiago Rios, M.D.
NPI 1396846119ActiveIndividual· Internal Medicine, Hematology & Oncology· Cidra, Puerto Rico, PR
Internal Medicine, Hematology & Oncology (M.D.) in Cidra, Puerto Rico, Puerto Rico, trained at Ponce School of Medicine (class of 2002). Part D covered 248 prescriptions written in 2024, 77% of them generic. Abbvie Inc. was the largest of 25 companies reporting payments in 2025, $3,111 in all, mostly food and beverage.
Overview
| NPI | 1396846119 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Sep 26, 2006 |
| Last updated in NPPES | Feb 11, 2015 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Hematology & Oncology Primary | 207RH0003X | 16015 | PR |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Hematology/Oncology (PR) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 248 · 300 30-day fills |
|---|---|
| Patients | 52 |
| Total drug cost | $639,190 |
| Generic share | 77% of claims |
Education and affiliations
| Medical school | Ponce School of Medicine |
|---|---|
| Graduation year | 2002 |
| Medicare specialty | Hematology/Oncology |
| Secondary specialties | Internal Medicine |
Medical group
- Caribbean Cancer Care Services LLCYauco, PR · 6 clinicians
Industry payments (Open Payments)
- 2025$3,111 · 121 payments from 25 companies
- 2024$2,571 · 110 payments from 20 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Abbvie Inc. | $545.01 | 16 |
| Astrazeneca Pharmaceuticals LP | $482.16 | 21 |
| E.R. Squibb & Sons, L.L.C. | $348.21 | 11 |
| Janssen Pharmaceuticals, Inc | $310.38 | 13 |
| Merck Sharp & Dohme LLC | $300.26 | 15 |
What the 2025 payments were for
- Food and Beverage$3,011 · 120 payments
- Education$99.99 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records